Clinical Trial Update: Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and feasibility of allogeneic stem cell transplantation from MHC-mismatched related donors in patients with advanced Ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED